Biotech

Business News

ELEVAI Labs Posts Record Full Year 2023 and Q4 Earnings

The company also reported record Q4 2023 revenue of $698,591, up 403% over the previous quarter. Elevai Labs Inc. (NASDAQ:…

Read More »
Business News

ELEVAI Labs Posts Q3 2023 Earnings, Reports Record Quarterly Revenue

Last Updated: ELEVAI Labs (NASDAQ: ELAB), a medical aesthetic company specializing in physician-dispensed skincare, today reported its fiscal 2023 Q3…

Read More »
Business News

ELEVAI Labs Expands Into European Market With Signing of New Partnership

Last Updated: ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare is pleased to announce its new…

Read More »
Business News

ELEVAI Labs Inks Licensing Deal With Yuva Biosciences to Develop New Topical Skincare Formulations and Aesthetics Products (VIDEO)

Last Updated: ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, announced today the signing of a…

Read More »
Business News

Capitalist Countdown: Wealthy VC’s Top 5 Investing News Stories of the Week

Last Updated: Welcome to Wealthy VC’s Capitalist Countdown The Capitalist Countdown is a weekly series that features the biggest stories from the…

Read More »
Business News

Neuralink: A $5 Billion Bet on the Future Despite Uncertain Road to Market

Updated Neuralink Is Valued at a $5 Billion Valuation. A Bet on the Future of Neural Technology Despite Uncertain Road…

Read More »
Business News

Capitalist Countdown: Wealthy VC’s Top 5 Investing News Stories of the Week

Welcome to Wealthy VC’s Capitalist Countdown The Capitalist Countdown is a weekly series that features the biggest stories from the market’s hottest…

Read More »
Business News

Johnson & Johnson, Drug Distributors Finalize $26 Billion Opioid Settlement

While the COVID-19 Pandemic Has Been Dominating the Headlines for the Last Few Years, There’s Another Long-Standing Public Health Crisis…

Read More »
Wealthy Biotech Trader

Pfizer’s Says its New COVID Pill Cuts Risks of Hospitalization, Death By 90%

Nearly two years into the COVID-19 pandemic and after rigorous testing, we’re starting to see some game-changing medications being introduced…

Read More »
Wealthy Biotech Trader

Investors Shift Focus From Vaccine Stocks to COVID Pill Stocks

Nearly two years since the COVID-19 pandemic began and almost one year since the various COVID-19 vaccines started to roll…

Read More »
Back to top button